Acumen Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ABOS)

Historical Holders from Q3 2021 to Q1 2025

Symbol
ABOS on Nasdaq
CUSIP
00509G209
Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
60.5M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
42.5M
Holdings value
$73.1M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
77
Number of buys
37
Number of sells
-28
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Acumen Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ABOS)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RA CAPITAL MANAGEMENT, L.P. 24.8% $19.1M 15M RA Capital Management, L.P. Mar 27, 2025

Institutional Holders of Acumen Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ABOS)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 63.5K $70.1K -$16.8K $1.11 2
2024 Q4 42.5M $73.1M -$2.31M $1.72 77
2024 Q3 43.6M $108M -$212K $2.48 72
2024 Q2 43.6M $105M +$1.21M $2.42 82
2024 Q1 1.31M $5.26M -$1.65M $4.05 13
2023 Q4 38.4M $148M -$20.5M $3.84 67
2023 Q3 43.2M $179M +$71.1M $4.15 63
2023 Q2 26.3M $127M -$5.31M $4.81 49
2023 Q1 27.8M $113M -$4.65M $4.06 60
2022 Q4 28.7M $155M -$5.55M $5.40 59
2022 Q3 27.5M $276M +$19.5M $10.03 48
2022 Q2 25.6M $120M -$6.03M $4.70 44
2022 Q1 27.1M $106M -$3.03M $3.91 53
2021 Q4 25.5M $173M -$1.79M $6.76 48
2021 Q3 24.1M $357M +$307M $14.86 41